Data manipulation / fraud in BE [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2020-10-21 09:56 (237 d 23:34 ago) – Posting: # 22041
Views: 688

Hi all,

a new paper was published dealing with detection of data integrity issues in BE, in particular a type of fraud that is prevalent according to regulators. The manipulation does not leave a paper trail or audit trail, and is not necessarily visible by onsite inspection. But it can be visualised or detected by certain analyses.

Regulators have been making extensive use of analyses produced through the software software described in the paper ("Buster" and "SaToWIB" routines) and it has been used to raise potential serious risks to public health and thus for referral triggering.

You can find the paper here.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,523 posts in 4,499 threads, 1,523 registered users;
online 5 (0 registered, 5 guests [including 5 identified bots]).
Forum time: Wednesday 09:30 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5